European ‘NAFLD Preparedness Index’ — Is Europe ready to meet the challenge of fatty liver disease?

Autor: Manuel Romero-Gómez, Patrizia Carrieri, Mattias Ekstedt, Shira Zelber-Sagi, Katja Novak, Vlad Ratziu, Quentin M. Anstee, Frank Tacke, Adam Palayew, Jeffrey V. Lazarus, Helena Cortez-Pinto, Giulio Marchesini

Publikováno v: JHEP Reports Innovation in Hepatology
JHEP Reports Innovation in Hepatology, Elsevier, 2021, 3 (2), pp.100234. ⟨10.1016/j.jhepr.2021.100234⟩
Digital.CSIC. Repositorio Institucional del CSIC
instname
JHEP Reports
JHEP Reports, Vol 3, Iss 2, Pp 100234-(2021)

[Background & Aims] Non-alcoholic fatty liver disease (NAFLD), which is closely associated with obesity, metabolic syndrome, and diabetes, is a highly prevalent emerging condition that can be optimally managed through a multidisciplinary patient-cent

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::237265ca3a905978c88b2731dd069191
https://hal.sorbonne-universite.fr/hal-03174867

Advances in multi-omics study of biomarkers of glycolipid metabolism disorder.

Autor: Fang X; Institute of Metabolic Diseases, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China.; Graduate College, Beijing University of Chinese Medicine, Beijing 100029, China., Miao R; Institute of Metabolic Diseases, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China.; Graduate College, Beijing University of Chinese Medicine, Beijing 100029, China., Wei J; Changchun University of Chinese Medicine, Jilin 130117, China., Wu H; Graduate College, Beijing University of Chinese Medicine, Beijing 100029, China., Tian J; Institute of Metabolic Diseases, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China.

Publikováno v: Computational and structural biotechnology journal [Comput Struct Biotechnol J] 2022 Oct 25; Vol. 20, pp. 5935-5951. Date of Electronic Publication: 2022 Oct 25 (Print Publication: 2022).

Non-alcoholic fatty liver disease: A patient guideline.

Autor: Francque SM; Department of Gastroenterology and Hepatology, Antwerp University Hospital, Antwerp, Belgium.; Laboratory of Experimental Medicine and Paediatrics (LEMP), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.; InflaMed Centre of Excellence, University of Antwerp, Antwerp, Belgium.; Translational Sciences in Inflammation and Immunology, University of Antwerp, Antwerp, Belgium., Marchesini G; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy.; Department of Medical and Surgical Sciences, 'Alma Mater' University, Bologna, Italy., Kautz A; Kautz gUG, Cologne, Germany., Walmsley M; PSC Support, Oxford, United Kingdom., Dorner R; Kautz gUG, Cologne, Germany., Lazarus JV; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Spain., Zelber-Sagi S; School of Public Health, Faculty of Social Welfare and Health Sciences, University of Haifa, Haifa, Israel.; Department of Gastroenterology and Hepatology, The Tel-Aviv Medical Center, Tel-Aviv, Israel., Hallsworth K; Newcastle NIHR Biomedical Research Centre, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK.; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Busetto L; Department of Medicine, University of Padova, Italy.; European Association for the Study of Obesity., Frühbeck G; Department of Endocrinology & Nutrition, University of Navarra Clinic, IdiSNA, CIBEROBN, Pamplona, Spain.; European Association for the Study of Obesity., Dicker D; Department of Internal Medicine, Rabin Medical Center Hasharon Hospital, Tikva, Israel.; European Association for the Study of Obesity., Woodward E; European Association for the Study of Obesity., Korenjak M; European Liver Patients' Association., Willemse J; Liver Patients International., Koek GH; Department of Internal Medicine, Division of Gastroenterology and Hepatology, Maastricht University Medical Centre, Maastricht, the Netherlands.; School of Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University, Maastricht, the Netherlands., Vinker S; Department of Family Medicine, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; World Organization of Family Doctors (WONCA).; European General Practice Research Network (EGPRN).; Israel Association of Family Physicians, Israel.; Leumit Health Services, Tel Aviv, Israel., Ungan M; World Organization of Family Doctors (WONCA)., Mendive JM; Training Unit of Family Medicine, Catalan Institute of Health, Barcelona, Spain.; European Society for Primary Care Gastroenterology., Lionis C; European Society for Primary Care Gastroenterology.; Clinic of Social and Family Medicine, School of Medicine, University of Crete, Heraklion, Greece.

Publikováno v: JHEP reports : innovation in hepatology [JHEP Rep] 2021 Sep 17; Vol. 3 (5), pp. 100322. Date of Electronic Publication: 2021 Sep 17 (Print Publication: 2021).

Lifestyle interventions for non-alcoholic fatty liver disease.

Autor: Ahmed IA; The Center for Natural Products Research and Drug Discovery (CENAR), Wellness Research Cluster, University of Malaya, 50603 Kuala Lumpur, Malaysia., Mikail MA; Department of Biomedical Science, Faculty of Science, Lincoln University College, Malaysia., Mustafa MR; The Center for Natural Products Research and Drug Discovery (CENAR), Wellness Research Cluster, University of Malaya, 50603 Kuala Lumpur, Malaysia., Ibrahim M; International Islamic University Malaysia, Kuantan Campus, Malaysia., Othman R; The Center for Natural Products Research and Drug Discovery (CENAR), Wellness Research Cluster, University of Malaya, 50603 Kuala Lumpur, Malaysia.

Publikováno v: Saudi journal of biological sciences [Saudi J Biol Sci] 2019 Nov; Vol. 26 (7), pp. 1519-1524. Date of Electronic Publication: 2019 Jan 03.